SGLT2-IN-4
SGLT2-IN-4 (Compound 1) is a selective and orally active sodium-dependent glucose cotransporter-2 (SGLT2) inhibitor. SGLT2-IN-4 can increase the proportion of protein α-helix and enhance the stability of the SGLT2-D201A mutant. SGLT2-IN-4 can be used for the research of type 2 diabetes[1].
Product Specifications
UNSPSC
12352005
Target
SGLT
Related Pathways
Membrane Transporter/Ion Channel
Field of Research
Metabolic Disease
Smiles
[H][C@@]1(O[C@H]([C@@H]([C@H]([C@@H]1O)O)O)CO)C2=C(C=C(C(CC3=CC=C(C=C3)OCC)=C2)Cl)CCOCCO
Molecular Formula
C25H33ClO8
Molecular Weight
496.98
References & Citations
[1]Haque A, et al. Identification of New Small-Molecule SGLT2 Inhibitors: In-Silico Approach to Therapeutics for Diabetes-Related Complications[J]. ACS Omega, 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
SGLT2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
123894-ML490 100 µL
BCL3 (B Cell Lymphoma 3 Protein, BCL-3, Proto-oncogene BCL3, BCL4, D19S37) (MaxLight 490)
Sign In for Pricing
View Details